NovelStem International NSTM
OTC NSTM
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovelStem International (NSTM) Return on Equity [ROE] (2011 - 2023)

Updated

NovelStem International's Return on Equity [ROE] came in at -897.93% for Q2 2024, down 855.01 percentage points from the prior quarter.

Analysis

NovelStem International (NSTM) Return on Equity [ROE] (2011 - 2023) Analysis & Trends

For FY2022, NovelStem International's Return on Equity [ROE] was -19.93%, down 16.26 percentage points from FY2021.

  • Going back by year, Return on Equity [ROE] was -3.67% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 NovelStem International 493,324.54 346,279.54 - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -897.93%
Mar 31, 2023 -42.91%
Dec 31, 2022 -22.43%
Sep 30, 2022 -19.70%
Jun 30, 2022 -14.91%
Mar 31, 2022 347.95%
Dec 31, 2021 292.69%
Sep 30, 2021 44.18%
Sep 30, 2013 70.49%
Jun 30, 2013 46.15%
Mar 31, 2013 43.10%
Dec 31, 2012 54.63%
Sep 30, 2012 -9.94%
Jun 30, 2012 -45.19%
Mar 31, 2012 -38.88%
Dec 31, 2011 -46.62%
Sep 30, 2011 -6.79%
API Access

NovelStem International Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NSTM&period=max&api_key=YOUR_API_KEY